Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.

scientific article published on 11 March 2017

Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10689-017-9978-9
P698PubMed publication ID28285342

P50authorIelizaveta GorodetskaQ86490820
Nataliia M KhranovskaQ92988639
Mariia InomistovaQ95966407
Zoia RossokhaQ95966410
Svitlana KyriachenkoQ95966412
Svitlana SergaQ56334616
Iryna KozeretskaQ56334617
Ludmila OstapchenkoQ56952052
P2093author name stringO Popova
A Peresunko
H Salomakhina
N Kmit'
N Tsip
O Kolesnik
O Manzhura
O Skachkova
S Demydov
T Lahuta
V Svintsitsky
P2860cites workSimple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCRQ78077814
High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancerQ84732910
Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from RussiaQ24680712
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutationQ28207617
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2Q28212276
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in HungaryQ33900686
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.Q34103057
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancerQ34145544
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testingQ34228853
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populationsQ34705352
Breast cancer risk among male BRCA1 and BRCA2 mutation carriersQ34718829
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and controlQ36117690
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from UkraineQ36161162
Cancer risks among BRCA1 and BRCA2 mutation carriersQ36610578
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patientsQ37147699
The contribution of BRCA1 and BRCA2 to ovarian cancerQ37453854
High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in LatviaQ43522641
Hereditary ovarian cancer in Poland.Q43683502
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, CanadaQ44116893
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesQ44221699
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.Q45906306
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.Q46922759
Cultural aspects of healthy BRCA carriers from two ethnocultural groupsQ47656975
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.Q55042194
Mutational analysis of theBRCA1 gene in 30 Czech ovarian cancer patientsQ61896436
High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from BelarusQ62583327
BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial casesQ74449532
P433issue4
P921main subjectUkraineQ212
ovarian cancerQ172341
P304page(s)471-476
P577publication date2017-03-11
P1433published inFamilial CancerQ15761917
P1476titlePrevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.
P478volume16